Tagged with Drugs

How Today’s Specialty Medicines are Driving the Future of Engagement
Fabrizio Chines – President & CEO, SIFI
Key Features of Orphan Drug Registration in Singapore, Malaysia, Philippines, and Vietnam
Orphan Drugs: Building the Regulatory Framework in the Czech Republic
David López García – Country Manager, BioMarin Mexico
Tamás Demeter – Country Manager, AOP Orphan, Hungary
Jan Krejčí – Country Manager, Ewopharma, Czech Republic
Myriam Hakim – General Manager GCC, Kyowa Kirin (January 2020)
UAE Accelerated Drug Approvals
UAE: A World Leader for Early Access to Innovation
China Cracks Down on Counterfeit and Substandard Drugs
Chinese Pharma’s Latest Race to the Bottom on Pricing
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here